Juvelook® PLA-Based Dermal Rejuvenation System
PDLLA 42.4mg + HA 7.5mg per vial
Juvelook® is an FDA/KFDA/CE-approved dermal filler combining poly-D,L-lactic acid (PDLLA) and hyaluronic acid. Clinical studies show 89% patient satisfaction with visible collagen neogenesis at 4 weeks. The dual-phase formula provides immediate volumization and sustained collagen stimulation, maintaining results for 24-30 months in 92% of cases with a 3-session protocol.
- Dual-Action Formula: Immediate HA volumization + sustained PDLLA collagen stimulation (up to 72% increase at 6 months)
- Longevity: Results persist 24+ months post-treatment cycle (3 sessions)
- Safety Profile: 0.3% adverse event rate in clinical trials (FDA Phase III data)
- Precision Delivery: 31G needle compatibility for intradermal placement at optimal depth
PDLLA + HA formulation
Optimized PDLLA microspheres
Lyophilized powder
Sterile saline solution
Standard unopened duration
Contraindications: Pregnancy, active skin infections, or known hypersensitivity to lactic acid derivatives
Adverse Effects: Minimal (0.3% rate in clinical trials)
Professional Note: Individual results may vary based on skin type, age, and treatment adherence (12-15% variation observed)
• Reconstitute with appropriate volume of sterile saline, allow hydration time
• Use linear threading technique for optimal distribution
• Apply cold compress post-treatment, avoid UV exposure
• Monitor for hypersensitivity reactions during initial administration
• Manufacturer not liable for improper storage or reconstitution errors
We are an authorized wholesale distributor of medical aesthetic products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be administered by qualified medical professionals with appropriate certification. Product specifications may vary by market – please confirm exact parameters with our team. Product images may differ from actual packaging.
Reviews
There are no reviews yet.